Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion.
第一作者:
Zhao,Liang
第一单位:
Department of Hematology, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue, Guangzhou, Guangdong, China.
作者:
主题词
人类(Humans);回顾性研究(Retrospective Studies);造血干细胞移植(Hematopoietic Stem Cell Transplantation);移植, 同种(Transplantation, Homologous);免疫疗法, 过继(Immunotherapy, Adoptive);移植物抗宿主病(Graft vs Host Disease);抗原, CD19(Antigens, CD19);淋巴细胞(Lymphocytes)
DOI
10.1007/s13577-023-00934-2
PMID
37418233
发布时间
2023-08-23
- 浏览0

Human cell
1716-1728页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文